Quarterly report pursuant to Section 13 or 15(d)

Derivative Liabilities (Details) - Schedule of Measured at Fair Value on a Recurring Basis

v3.24.1.1.u2
Derivative Liabilities (Details) - Schedule of Measured at Fair Value on a Recurring Basis
 3 Months Ended
Mar. 31, 2024
USD ($)
Schedule of Summary of the Changes in the Fair Value of Derivative Liabilities [Line Items]  
Beginning balance $ 58
Change in fair value of derivative liabilities 191
Ending balance 249
Public SPAC Warrants [Member]  
Schedule of Summary of the Changes in the Fair Value of Derivative Liabilities [Line Items]  
Beginning balance 58 [1]
Change in fair value of derivative liabilities 191 [1]
Ending balance 249 [1]
Private SPAC Warrants [Member]  
Schedule of Summary of the Changes in the Fair Value of Derivative Liabilities [Line Items]  
Beginning balance
Change in fair value of derivative liabilities
Ending balance
PIPE Warrants [Member]  
Schedule of Summary of the Changes in the Fair Value of Derivative Liabilities [Line Items]  
Beginning balance
Change in fair value of derivative liabilities
Ending balance
Other Warrants [Member]  
Schedule of Summary of the Changes in the Fair Value of Derivative Liabilities [Line Items]  
Beginning balance
Change in fair value of derivative liabilities
Ending balance
[1] There are 15,132 Public SPAC warrants, 662 Private SPAC warrants, 6,748 PIPE warrants and 234 Other warrants outstanding as of March 31, 2024; all but the Public SPAC warrants are valued at zero as of the current period end.